title: Postmenopausal estrogen and progestin effects on the serum proteome.
abstract: BACKGROUND
  Women's Health Initiative randomized trials of postmenopausal hormone therapy reported intervention effects on several clinical outcomes, with some important differences between estrogen alone and estrogen plus progestin. The biologic mechanisms underlying these effects, and these differences, have yet to be fully elucidated.
  
  
  METHODS
  Baseline serum samples were compared with samples drawn 1 year later for 50 women assigned to active hormone therapy in both the estrogen-plus-progestin and estrogen-alone randomized trials, by applying an in-depth proteomic discovery platform to serum pools from 10 women per pool.
  
  
  RESULTS
  In total, 378 proteins were quantified in two or more of the 10 pooled serum comparisons, by using strict identification criteria. Of these, 169 (44.7%) showed evidence (nominal P < 0.05) of change in concentration between baseline and 1 year for one or both of estrogen-plus-progestin and estrogen-alone groups. Quantitative changes were highly correlated between the two hormone-therapy preparations. A total of 98 proteins had false discovery rates < 0.05 for change with estrogen plus progestin, compared with 94 for estrogen alone. Of these, 84 had false discovery rates <0.05 for both preparations. The observed changes included multiple proteins relevant to coagulation, inflammation, immune response, metabolism, cell adhesion, growth factors, and osteogenesis. Evidence of differential changes also was noted between the hormone preparations, with the strongest evidence in growth factor and inflammation pathways.
  
  
  CONCLUSIONS
  Serum proteomic analyses yielded a large number of proteins similarly affected by estrogen plus progestin and by estrogen alone and identified some proteins and pathways that appear to be differentially affected between the two hormone preparations; this may explain their distinct clinical effects.
authors.affiliation: Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.
authors.forename: Sharon J
authors.initials: SJ
authors.lastname: Pitteri
authors.forename: Samir M
authors.initials: SM
authors.lastname: Hanash
authors.forename: Aaron
authors.initials: A
authors.lastname: Aragaki
authors.forename: Lynn M
authors.initials: LM
authors.lastname: Amon
authors.forename: Lin
authors.initials: L
authors.lastname: Chen
authors.forename: Tina
authors.initials: T
authors.lastname: Busald Buson
authors.forename: Sophie
authors.initials: S
authors.lastname: Paczesny
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Katayama
authors.forename: Hong
authors.initials: H
authors.lastname: Wang
authors.forename: Melissa M
authors.initials: MM
authors.lastname: Johnson
authors.forename: Qing
authors.initials: Q
authors.lastname: Zhang
authors.forename: Martin
authors.initials: M
authors.lastname: McIntosh
authors.forename: Pei
authors.initials: P
authors.lastname: Wang
authors.forename: Charles
authors.initials: C
authors.lastname: Kooperberg
authors.forename: Jacques E
authors.initials: JE
authors.lastname: Rossouw
authors.forename: Rebecca D
authors.initials: RD
authors.lastname: Jackson
authors.forename: Joann E
authors.initials: JE
authors.lastname: Manson
authors.forename: Judith
authors.initials: J
authors.lastname: Hsia
authors.forename: Simin
authors.initials: S
authors.lastname: Liu
authors.forename: Lisa
authors.initials: L
authors.lastname: Martin
authors.forename: Ross L
authors.initials: RL
authors.lastname: Prentice